D. Dupont

发表

Biochemical properties of plasminogen activator inhibitor-1.

P. Andreasen, D. Dupont, J. B. Madsen, 2009, Frontiers in bioscience.

Mutational analysis of plasminogen activator inhibitor-1.

P. Andreasen, D. Dupont, T. Wind, 2003, European journal of biochemistry.

Enhanced Anticoagulation Activity of Functional RNA Origami

Ashley C. Brown, J. Kjems, E. Andersen, 2020, bioRxiv.

Plasminogen activator inhibitor-1 and tumour growth, invasion, and metastasis

P. Andreasen, D. Dupont, J. Bødker, 2004, Thrombosis and Haemostasis.

A Conjugate of Two tPA-Binding RNA Aptamers Efficiently Inhibits Fibrinolysis.

P. Andreasen, D. Dupont, Nils Bjerregaard, 2017, Nucleic acid therapeutics.

University of Southern Denmark Blocking the proteolytic activity of zymogen matriptase with antibody-based inhibitors Tamberg,

K. Skjoedt, D. Dupont, J. Jensen, 2019 .

Blocking the proteolytic activity of zymogen matriptase with antibody-based inhibitors

K. Skjoedt, D. Dupont, J. Jensen, 2018, The Journal of Biological Chemistry.

A Peptide Accelerating the Conversion of Plasminogen Activator Inhibitor-1 to an Inactive Latent State

A. Gils, P. Declerck, P. Andreasen, 2008, Molecular Pharmacology.

Differential RNA aptamer affinity profiling on plasma as a potential diagnostic tool for bladder cancer

J. Enghild, K. Birkenkamp-Demtröder, J. Kjems, 2022, NAR cancer.

Biochemical and structural analyses suggest that plasminogen activators coevolved with their cognate protein substrates and inhibitors

S. Lovell, E. Füchtbauer, F. Panitz, 2019, The Journal of Biological Chemistry.

An RNA Aptamer Inhibits a Mutation-Induced Inactivating Misfolding of a Serpin.

P. Andreasen, T. Jørgensen, M. B. Trelle, 2016, Cell chemical biology.

Nanopore sequencing of brain-derived full-length circRNAs reveals circRNA-specific exon usage, intron retention and microexons

J. Kjems, M. Venø, D. Dupont, 2021, Nature Communications.

Protein-Binding RNA Aptamers Affect Molecular Interactions Distantly from Their Binding Sites

H. P. Sørensen, J. S. Pedersen, M. Ploug, 2015, PloS one.

Evidence for a Pre-latent Form of the Serpin Plasminogen Activator Inhibitor-1 with a Detached β-Strand 1C*

A. Gils, P. Declerck, P. Andreasen, 2006, Journal of Biological Chemistry.

Characterisation of aptamer–target interactions by branched selection and high-throughput sequencing of SELEX pools

Jørgen Kjems, J. Kjems, P. Andreasen, 2015, Nucleic acids research.

Targeting Tumor Cell Invasion and Dissemination In Vivo by an Aptamer That Inhibits Urokinase-type Plasminogen Activator through a Novel Multifunctional Mechanism

M. Ploug, H. Gårdsvoll, P. Andreasen, 2012, Molecular Cancer Research.

Serum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding.

J. Kjems, F. Ducongé, B. Tavitian, 2010, RNA.

Building a Molecular Trap for a Serine Protease from Aptamer and Peptide Modules.

P. Andreasen, D. Dupont, J. Jensen, 2016, Bioconjugate chemistry.

Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis.

P. Andreasen, D. Dupont, J. Bødker, 2004, Thrombosis and haemostasis.

RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1.

J. Kjems, P. Andreasen, D. Dupont, 2010, Biochemistry.

Antigen footprint governs activation of the B cell receptor

Alexandra S. Eklund, J. Kjems, S. Thiel, 2022, Nature Communications.

A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry

J. Kjems, F. Pedersen, V. Birkedal, 2021, Proceedings of the National Academy of Sciences.

Nucleic acid aptamers against proteases.

P. Andreasen, D. Dupont, P A Andreasen, 2011, Current medicinal chemistry.

Tumor-targeted polydiacetylene micelles for in vivo imaging and drug delivery.

F. Ducongé, B. Tavitian, A. Garofalakis, 2011, Small.

Tissue-type plasminogen activator-binding RNA aptamers inhibiting low-density lipoprotein receptor family-mediated internalisation

P. Andreasen, D. Dupont, Nicky Helsen, 2015, Thrombosis and Haemostasis.

Dissecting the effect of RNA aptamer binding on the dynamics of plasminogen activator inhibitor 1 using hydrogen/deuterium exchange mass spectrometry.

P. Andreasen, T. Jørgensen, M. B. Trelle, 2014, ACS chemical biology.

An Albumin-Oligonucleotide Assembly for Potential Combinatorial Drug Delivery and Half-Life Extension Applications

D. Schaffert, J. Wengel, K. Howard, 2017, Molecular therapy. Nucleic acids.

Interactions of plasminogen activator inhibitor-1 with vitronectin involve an extensive binding surface and induce mutual conformational rearrangements.

J. Anagli, M. Ploug, H. Gårdsvoll, 2009, Biochemistry.

Methods To Identify Aptamers against Cell Surface Biomarkers

F. Ducongé, D. Dupont, Frédéric Ducongé, 2011, Pharmaceuticals.

Small-Molecule Probes for Affinity-Guided Introduction of Biocompatible Handles on Metal-Binding Proteins.

J. Enghild, J. Kjems, K. Gothelf, 2018, Bioconjugate chemistry.

Nanopore sequencing of full-length circRNAs in human and mouse brains reveals circRNA-specific exon usage and intron retention

J. Kjems, M. Venø, D. Dupont, 2019, bioRxiv.

Construction of a plasminogen activator inhibitor‐1 variant without measurable affinity to vitronectin but otherwise normal

P. Andreasen, D. Dupont, J. Bødker, 2004, FEBS letters.

Expected and unexpected features of protein‐binding RNA aptamers

P. Andreasen, D. Dupont, Nils Bjerregaard, 2016, Wiley interdisciplinary reviews. RNA.

Multivalent Aptamer‐Functionalized Single‐Strand RNA Origami as Effective, Target‐Specific Anticoagulants with Corresponding Reversal Agents

Ashley C. Brown, J. Kjems, E. Andersen, 2021, Advanced healthcare materials.

Targeting Tumor Cell Invasion and Dissemination In Vivo by an Aptamer That Inhibits Urokinase-type Plasminogen Activator through a Novel Multifunctional Mechanism

M. Ploug, H. Gårdsvoll, P. Andreasen, 2012, Molecular Cancer Research.

In vivo validation of free-space fluorescence tomography using nuclear imaging.

Anikitos Garofalakis, Albertine Dubois, Bertrand Tavitian, 2010, Optics letters.

Tissue-type plasminogen activator-binding RNA aptamers inhibiting low-density lipoprotein receptor family-mediated internalisation

P. Andreasen, D. Dupont, Nicky Helsen, 2015, Thrombosis and Haemostasis.

Characterisation of aptamer–target interactions by branched selection and high-throughput sequencing of SELEX pools

J. Kjems, P. Andreasen, Niels Larsen, 2015, Nucleic acids research.